VolitionRx issues shares for note conversions, updates outstanding share count

VolitionRx Limited issued shares to satisfy convertible promissory note conversions, as reported in a Securities and Exchange Commission filing. The company issued 706,214 shares to Lind Global Asset Management XII LLC on September 2 to meet a $250,000 note conversion obligation. An additional 707,236 shares were issued on September 10 to the same entity to satisfy a $215,000 conversion obligation.

These transactions were conducted under exemptions provided by the Securities Act of 1933 and/or Regulation D, without commissions, public offerings, or general solicitation. VolitionRx currently has 27,903,326 shares of common stock issued and outstanding, with the stock trading near its 52-week low at $0.29. Despite financial challenges, including a wider-than-expected loss and lower-than-forecast revenue in Q2 2026, the company highlighted reductions in operating expenses and advancements in partnerships and scientific research.